SESEN BIO INC's ticker is SESN and the CUSIP is 817763105. A total of 75 filers reported holding SESEN BIO INC in Q2 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $0 | – | 418 | -61.2% | 0.00% | – |
Q3 2022 | $0 | – | 1,076 | +266.0% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 294 | -97.9% | 0.00% | – |
Q1 2022 | $8,000 | -78.9% | 14,068 | -69.9% | 0.00% | – |
Q4 2021 | $38,000 | +123.5% | 46,720 | +108.3% | 0.00% | – |
Q3 2021 | $17,000 | -69.1% | 22,428 | +89.5% | 0.00% | – |
Q2 2021 | $55,000 | – | 11,836 | +9763.3% | 0.00% | – |
Q1 2021 | $0 | – | 120 | +11900.0% | 0.00% | – |
Q4 2020 | $0 | -100.0% | 1 | -99.9% | 0.00% | – |
Q3 2020 | $2,000 | 0.0% | 1,366 | -61.2% | 0.00% | – |
Q2 2020 | $2,000 | 0.0% | 3,521 | +9.5% | 0.00% | – |
Q1 2020 | $2,000 | 0.0% | 3,216 | +151.8% | 0.00% | – |
Q4 2019 | $2,000 | 0.0% | 1,277 | -10.2% | 0.00% | – |
Q3 2019 | $2,000 | +100.0% | 1,422 | +184.4% | 0.00% | – |
Q2 2019 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q1 2019 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q4 2018 | $1,000 | -91.7% | 500 | -91.0% | 0.00% | – |
Q3 2018 | $12,000 | +1100.0% | 5,541 | +1008.2% | 0.00% | – |
Q2 2018 | $1,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,711,672 | $2,311,000 | 0.25% |
Eversept Partners, LP | 1,559,824 | $2,105,762 | 0.25% |
Virtu Financial LLC | 270,004 | $365,000 | 0.04% |
GSA CAPITAL PARTNERS LLP | 147,452 | $199,000 | 0.03% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 838,500 | $1,132,000 | 0.02% |
MIRABELLA FINANCIAL SERVICES LLP | 88,350 | $119,000 | 0.02% |
Stratos Wealth Partners, LTD. | 263,300 | $355,000 | 0.01% |
AJ WEALTH STRATEGIES, LLC | 79,365 | $107,000 | 0.01% |
Schonfeld Strategic Advisors LLC | 349,176 | $471,000 | 0.01% |
Qube Research & Technologies Ltd | 330,303 | $446,000 | 0.01% |